Bioter S.A. (BIOT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Bioter S.A. (BIOT) has a cash flow conversion efficiency ratio of 0.023x as of December 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-2.46 Million ≈ $-2.88 Million USD) by net assets (€-106.17 Million ≈ $-124.12 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Bioter S.A. - Cash Flow Conversion Efficiency Trend (2014–2022)
This chart illustrates how Bioter S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read BIOT total debt and obligations for a breakdown of total debt and financial obligations.
Bioter S.A. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bioter S.A. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Pool Safe Inc
V:POOL
|
-3.557x |
|
Nicoccino Holding AB
ST:NICO
|
-0.234x |
|
Sodas Sodyum Sanayi AS
IS:SODSN
|
0.362x |
|
Mawson Infrastructure Group Inc
NASDAQ:MIGI
|
0.090x |
|
Abits Group Inc.
NASDAQ:ABTS
|
-0.059x |
|
Triple Point Social Housing REIT PLC
LSE:SOHO
|
0.034x |
|
Franchise Brands PLC
LSE:FRAN
|
0.043x |
|
H&T Group plc
LSE:HAT
|
0.033x |
Annual Cash Flow Conversion Efficiency for Bioter S.A. (2014–2022)
The table below shows the annual cash flow conversion efficiency of Bioter S.A. from 2014 to 2022. For the full company profile with market capitalisation and key ratios, see BIOT company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-12-31 | €-106.17 Million ≈ $-124.12 Million |
€-9.46 Million ≈ $-11.06 Million |
0.089x | +34.82% |
| 2021-12-31 | €-96.49 Million ≈ $-112.81 Million |
€-6.38 Million ≈ $-7.45 Million |
0.066x | -36.34% |
| 2020-12-31 | €-87.69 Million ≈ $-102.52 Million |
€-9.10 Million ≈ $-10.64 Million |
0.104x | +51.53% |
| 2019-12-31 | €-93.64 Million ≈ $-109.48 Million |
€-6.41 Million ≈ $-7.50 Million |
0.068x | -17.40% |
| 2018-12-31 | €-85.02 Million ≈ $-99.39 Million |
€-7.05 Million ≈ $-8.24 Million |
0.083x | -57.38% |
| 2017-12-31 | €-71.39 Million ≈ $-83.47 Million |
€-13.89 Million ≈ $-16.24 Million |
0.195x | +47.08% |
| 2016-12-31 | €-54.16 Million ≈ $-63.32 Million |
€-7.16 Million ≈ $-8.38 Million |
0.132x | -46.53% |
| 2015-12-31 | €-35.44 Million ≈ $-41.43 Million |
€-8.77 Million ≈ $-10.25 Million |
0.247x | -34.62% |
| 2014-12-31 | €-25.33 Million ≈ $-29.61 Million |
€-9.58 Million ≈ $-11.20 Million |
0.378x | -- |
About Bioter S.A.
Bioter S.A. operates as a technical construction company in Greece and internationally. The company is involved in the execution of various projects, such as roads, ports, industrial-energy, electromechanical-communications, airports, war industries factories, etc., as well as private projects, such as offices, banks, bus stations, etc. The company was founded in 1961 and is based in Athens, Gree… Read more